196 related articles for article (PubMed ID: 22692983)
1. Brain isoprenoids farnesyl pyrophosphate and geranylgeranyl pyrophosphate are increased in aged mice.
Hooff GP; Wood WG; Kim JH; Igbavboa U; Ong WY; Muller WE; Eckert GP
Mol Neurobiol; 2012 Aug; 46(1):179-85. PubMed ID: 22692983
[TBL] [Abstract][Full Text] [Related]
2. Effects of 7,8-Dihydroxyflavone on Lipid Isoprenoid and Rho Protein Levels in Brains of Aged C57BL/6 Mice.
Ötzkan S; Muller WE; Gibson Wood W; Eckert GP
Neuromolecular Med; 2021 Mar; 23(1):130-139. PubMed ID: 33377988
[TBL] [Abstract][Full Text] [Related]
3. Regulation of the brain isoprenoids farnesyl- and geranylgeranylpyrophosphate is altered in male Alzheimer patients.
Eckert GP; Hooff GP; Strandjord DM; Igbavboa U; Volmer DA; Müller WE; Wood WG
Neurobiol Dis; 2009 Aug; 35(2):251-7. PubMed ID: 19464372
[TBL] [Abstract][Full Text] [Related]
4. Effects of farnesyl pyrophosphate accumulation on calvarial osteoblast differentiation.
Weivoda MM; Hohl RJ
Endocrinology; 2011 Aug; 152(8):3113-22. PubMed ID: 21586555
[TBL] [Abstract][Full Text] [Related]
5. Isoprenoids, small GTPases and Alzheimer's disease.
Hooff GP; Wood WG; Müller WE; Eckert GP
Biochim Biophys Acta; 2010 Aug; 1801(8):896-905. PubMed ID: 20382260
[TBL] [Abstract][Full Text] [Related]
6. Modulation of cholesterol, farnesylpyrophosphate, and geranylgeranylpyrophosphate in neuroblastoma SH-SY5Y-APP695 cells: impact on amyloid beta-protein production.
Hooff GP; Peters I; Wood WG; Müller WE; Eckert GP
Mol Neurobiol; 2010 Jun; 41(2-3):341-50. PubMed ID: 20405344
[TBL] [Abstract][Full Text] [Related]
7. Geranylgeranyl pyrophosphate is a potent regulator of HRD-dependent 3-Hydroxy-3-methylglutaryl-CoA reductase degradation in yeast.
Garza RM; Tran PN; Hampton RY
J Biol Chem; 2009 Dec; 284(51):35368-80. PubMed ID: 19776008
[TBL] [Abstract][Full Text] [Related]
8. Statins inhibit blastocyst formation by preventing geranylgeranylation.
Alarcon VB; Marikawa Y
Mol Hum Reprod; 2016 May; 22(5):350-63. PubMed ID: 26908642
[TBL] [Abstract][Full Text] [Related]
9. A rapid and sensitive assay for determining human brain levels of farnesyl-(FPP) and geranylgeranylpyrophosphate (GGPP) and transferase activities using UHPLC-MS/MS.
Hooff GP; Patel N; Wood WG; Müller WE; Eckert GP; Volmer DA
Anal Bioanal Chem; 2010 Oct; 398(4):1801-8. PubMed ID: 20730526
[TBL] [Abstract][Full Text] [Related]
10. Mevalonate Cascade and its Regulation in Cholesterol Metabolism in Different Tissues in Health and Disease.
Hashemi M; Hoshyar R; Ande SR; Chen QM; Solomon C; Zuse A; Naderi M
Curr Mol Pharmacol; 2017; 10(1):13-26. PubMed ID: 26758949
[TBL] [Abstract][Full Text] [Related]
11. Key Enzymes for the Mevalonate Pathway in the Cardiovascular System.
Zhang C; Jin DD; Wang XY; Lou L; Yang J
J Cardiovasc Pharmacol; 2021 Feb; 77(2):142-152. PubMed ID: 33538531
[TBL] [Abstract][Full Text] [Related]
12. Regulation of fatty acid synthesis by farnesyl pyrophosphate.
Murthy S; Tong H; Hohl RJ
J Biol Chem; 2005 Dec; 280(51):41793-804. PubMed ID: 16221687
[TBL] [Abstract][Full Text] [Related]
13. Quantitative determination of farnesyl and geranylgeranyl diphosphate levels in mammalian tissue.
Tong H; Wiemer AJ; Neighbors JD; Hohl RJ
Anal Biochem; 2008 Jul; 378(2):138-43. PubMed ID: 18457649
[TBL] [Abstract][Full Text] [Related]
14. Isoprenoids and tau pathology in sporadic Alzheimer's disease.
Pelleieux S; Picard C; Lamarre-Théroux L; Dea D; Leduc V; Tsantrizos YS; Poirier J
Neurobiol Aging; 2018 May; 65():132-139. PubMed ID: 29476987
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of farnesyl pyrophosphate (FPP) and/or geranylgeranyl pyrophosphate (GGPP) biosynthesis and its implication in the treatment of cancers.
Waller DD; Park J; Tsantrizos YS
Crit Rev Biochem Mol Biol; 2019 Feb; 54(1):41-60. PubMed ID: 30773935
[TBL] [Abstract][Full Text] [Related]
16. Geranylgeranyl-pyrophosphate, an isoprenoid of mevalonate cascade, is a critical compound for rat primary cultured cortical neurons to protect the cell death induced by 3-hydroxy-3-methylglutaryl-CoA reductase inhibition.
Tanaka T; Tatsuno I; Uchida D; Moroo I; Morio H; Nakamura S; Noguchi Y; Yasuda T; Kitagawa M; Saito Y; Hirai A
J Neurosci; 2000 Apr; 20(8):2852-9. PubMed ID: 10751437
[TBL] [Abstract][Full Text] [Related]
17. Isoprenoids responsible for protein prenylation modulate the biological effects of statins on pancreatic cancer cells.
Gbelcová H; Rimpelová S; Knejzlík Z; Šáchová J; Kolář M; Strnad H; Repiská V; D'Acunto WC; Ruml T; Vítek L
Lipids Health Dis; 2017 Dec; 16(1):250. PubMed ID: 29262834
[TBL] [Abstract][Full Text] [Related]
18. Farnesyl pyrophosphate regulates adipocyte functions as an endogenous PPARγ agonist.
Goto T; Nagai H; Egawa K; Kim YI; Kato S; Taimatsu A; Sakamoto T; Ebisu S; Hohsaka T; Miyagawa H; Murakami S; Takahashi N; Kawada T
Biochem J; 2011 Aug; 438(1):111-9. PubMed ID: 21605082
[TBL] [Abstract][Full Text] [Related]
19. The analytical determination of isoprenoid intermediates from the mevalonate pathway.
Nürenberg G; Volmer DA
Anal Bioanal Chem; 2012 Jan; 402(2):671-85. PubMed ID: 21789486
[TBL] [Abstract][Full Text] [Related]
20. Isoprenoid pyrophosphate analogues regulate expression of Ras-related proteins.
Holstein SA; Wohlford-Lenane CL; Wiemer DF; Hohl RJ
Biochemistry; 2003 Apr; 42(15):4384-91. PubMed ID: 12693933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
